Corveus Medical
Corveus Medical, based in Houston, TX, specializes in developing catheter-based devices for targeted nerve ablation to treat chronic heart failure, focusing on minimizing collateral tissue damage.
Company History
Corveus Medical, formerly known as Caridian Medical, was launched in 2022. The company is based in Houston, TX, USA, and operates within the healthcare industry, specifically focusing on medical devices. As an early-stage startup, Corveus Medical is part of the Y Combinator W22 batch.
Industry and Sector
Corveus Medical operates in the healthcare industry, with a specialized focus on medical devices. The company is working on innovative solutions within this sector, specifically targeting medical procedures related to nerve ablation. Its expertise lies in developing catheter-based devices designed to minimize collateral tissue damage during targeted nerve ablation processes.
Core Services
Corveus Medical specializes in creating catheter-based devices for targeted nerve ablation in the upper abdomen. These devices aim to treat conditions such as chronic heart failure and are designed to ensure minimal collateral tissue damage during ablation procedures. The company's solutions cater to both healthcare professionals and patients in need of advanced medical treatments.
Team and Locations
The team at Corveus Medical consists of three members based in Houston, TX, USA. The company focuses on developing its innovative medical devices and operates from its Houston location, serving regions including the United States of America, America/Canada, and offering partly remote services.
Geographical Reach
Corveus Medical serves multiple regions, including the United States of America and America/Canada. In addition to its local operations in Houston, Texas, the company offers remote and partly remote services, expanding its reach to broader geographical areas.